Brain metastasis from renal cell carcinoma

Area of Science:

• Oncology
• Neurosurgery
• Radiation Oncology

Background:

• Renal cell carcinoma (RCC) infrequently accounts for primary cancers but frequently metastasizes to the brain.
• Brain metastases from RCC exhibit a propensity for intratumoral hemorrhage and significant surrounding edema.
• Surgical resection is often emphasized but not always feasible due to tumor and patient factors.

Purpose of the Study:

• To evaluate the efficacy of stereotactic radiosurgery (SRS) in managing brain metastasis from RCC.
• To compare SRS outcomes with conventional treatments for RCC brain metastases.
• To highlight SRS as a potentially superior treatment modality for RCC brain metastases.

Main Methods:

• Review of existing literature on the management of brain metastasis from RCC.
• Analysis of outcomes associated with stereotactic radiosurgery (SRS) for RCC brain metastases.
• Comparison of SRS efficacy against conventional whole brain radiotherapy and surgical resection.

Main Results:

• Stereotactic radiosurgery (SRS) demonstrates excellent outcomes in controlling the tumor and reducing surrounding edema.
• RCC brain metastases show resistance to conventional whole brain radiotherapy.
• SRS is repeatable, allowing for management of new metastases that may arise.
• Adverse effects of SRS are generally acceptable with low incidence and severity.

Conclusions:

• Stereotactic radiosurgery (SRS) should be emphasized in the management of brain metastasis from renal cell carcinoma (RCC).
• SRS offers a viable and effective alternative, particularly when surgery is not possible or radiotherapy is insufficient.
• Individualized combined treatment strategies involving SRS may further improve patient outcomes.